USE OF A TOPICAL COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR (EGF) FOR DIABETIC FOOT AMPUTATION PREVENTION

• 1. 包含表皮生长因子(EGF)的局部用组合物用于预防糖尿病性截足的应用 [P] . 中国专利： CN104623632A . 2015-05-20
• 2. 包含表皮生长因子（EGF）的局部用组合物用于预防糖尿病性截足的应用 [P] . 中国专利： CN101374541A . 2009-02-25
• 3. USE OF A TOPICAL COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR (EGF) FOR DIABETIC FOOT AMPUTATION PREVENTION [P] . PT1970071E . 2015-02-06

  机译： 含有表皮生长因子（EGF）的局部组合物在糖尿病足预防中的应用

• 4. USE OF A TOPICAL COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR (EGF) FOR DIABETIC FOOT AMPUTATION PREVENTION [P] . PL1970071T3 . 2015-05-29

  机译： 含有表皮生长因子（EGF）的局部组合物在糖尿病足预防中的应用

• 5. USE OF A TOPICAL COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR (EGF) FOR DIABETIC FOOT AMPUTATION PREVENTION [P] . CA2635013C . 2015-09-29

  机译： 含有表皮生长因子（EGF）的局部组合物在糖尿病足预防中的应用

• 1. Effects of the Nocth signaling pathway on expression of inflammatory factors and transforming growth factors in diabetic foot ulcers [J] . Qiang Han, Guo-Bin Liu, Ren-Yan Huang, 海南医科大学学报（英文版） . 2021,第012期
• 2. Effects of the Nocth signaling pathway on expression of inflammatory factors and transforming growth factors in diabetic foot ulcers [J] . Qiang Han, Guo-Bin Liu, Ren-Yan Huang, 海南医科大学学报(英文版) . 2021,第012期
• 3. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial [J] . Kwang Hwan Park, Seung Hwan Han, Joon Pio Hong, Diabetes research and clinical practice . 2018,第期
• 4. Efficacy of Topical Recombinant Human Epidermal Growth Factor for Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis [J] . Yang Shaowei, Geng Zhijun, Ma Kui, The international journal of lower extremity wounds . 2016,第2期
• 5. Efficacy of topical application of beta urogastrone (recombinant human epidermal growth factor) in Wagner's Grade 1 and 2 diabetic foot ulcers: Comparative analysis of 50 patients [J] . Sanjeev Singla, Ramneesh Garg, Abhishek Kumar, Journal of Natural Science Biology and Medicine . 2014,第2期
• 6. Experimental Study of the Effects of Topical Fibrin Glue and Epidermal Growth Factor (EGF) on the Colon Anastomosis Healing Process [C] . G. Stanojevic, M. Jovanovic, M. Stojanovic, Societa? Italiana di Chirurgia Colo-Rettale . 2005
• 7. The Prevention of Foot Amputations in Diabetic Mexican Americans [D] . Escobedo, Cecilia R. 2021
• 8. Intralesional epidermal growth factor application is a potential therapeutic strategy to improve diabetic foot ulcer healing and prevent amputation [O] . Ömer Arda Çetinkaya, Süleyman Utku Çelik, Miraç Barış Erzincan, 2020
• 9. Intralesional Administration of Human Recombinant Epidermal Growth Factor Improves Healing and Reduces Amputations in Patients with Severe Diabetic Foot Ulcers [O] . Aristides L. Garcia Herrera, MD, PhD 2017

• 1. Risk Factors for Amputation in Patients with Diabetic Foot Diseases in Sokoto, Nigeria [J] . M. Oboirien ,S. P. Agbo ,L. O. Ajiboye . 健康（英文） . 2018,第5期
• 2. Study of gonadic growth factors: Seminal transforming growth factor-β1, epidermal growth factor and insulin-like growth factor-I and their relationship with male infertility [J] . Houda Amor ,Mounir Ajina ,Ali Saad . 生殖科学（英文） . 2014,第1期
• 3. Erratum: Author’s Affiliation Correction. Type Ⅱ human epidermal growth factor receptor heterogeneity is a poor prognosticator for type Ⅱ human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019;Aug 6;7 (15): 1964-1977) [J] . Akio Kaito ,Takeshi Kuwata ,Masanori Tokunaga . 世界临床病例杂志 . 2020,第021期
• 4. 一种含有表皮生长因子的抗衰老护肤组合产品的设计方案介绍 [C] . 杨平顺 ,张泽奇 . 第二届生物新技术背景下的皮肤健康与保健护理发展高峰论坛 . 2010
• 5. 中药外治对糖尿病足患者局部组织bFGF、VEGF表达的变化的影响研究 [A] . 王晓媛 . 2009